Back to search
Opsoclonus-myoclonus Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Opsoclonus-myoclonus Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Opsoclonus-myoclonus Syndrome trials you may qualify forThis phase II trial studies the side effects and how well carmustine, etoposide, cytarabine and melphalan together with antithymocyte globulin before a stem cel…
The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way b…
This randomized phase III trial is studying cyclophosphamide, prednisone, and immunoglobulin to see how well they work compared to cyclophosphamide and predniso…
The purpose of this study is to evaluate the feasibility of giving four weekly doses of Rituximab (anti-CD20 antibody) in the treatment of children with refract…
The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and co…
The purpose of this study is to reduce the symptoms of OMS by testing rituximab (Rituxan®), to remove B lymphocytes that make antibodies and trigger brain infla…